Laura Bernardini - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Laura Bernardini's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Laura Bernardini

Laura Bernardini

Verified

Vice President of News, National Desk, CNN

Washington

Biography

Supervising Producer for CNN's White House unit plus proud native Vermonter & links/retweets are not endorsements

Final Covers

White House

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 77

  • Genotype‐Phenotype Correlation in a Group of Italian Patients With Primary Ciliary Dyskinesia

    By Laura Petrarca, Valentina Guida, Raffaella Nenna, Alessandro De Luca, Marina Goldoni, Laura Bernardini Verified, Maria Conti, Giuseppe Cimino, Enrica Mancino, Laura Masuelli, Fabio Midulla, Piercarlo Poli| Wiley Online Library Verified Data Availability Statement The data that supports the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

    By Laura Petrarca, Valentina Guida, Raffaella Nenna, Alessandro De Luca, Marina Goldoni, Laura Bernardini Verified, Maria Conti, Giuseppe Cimino, Enrica Mancino, Laura Masuelli, Fabio Midulla, Piercarlo Poli · Wiley Online Library

    Apr. 05, 2025

  • Cancers | Free Full-Text | Investigating Physical, Social, Emotional, and Health Frailties of Cancer Survivors after Cancer Treatment: The Urgent Call for Tailored Multidisciplinary Survivorship Plans in Italy

    By Stefania Moramarco, Luigi De Angelis, Laura Bernardini Verified, Lorenza Marconi| MDPI@ All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

    By Stefania Moramarco, Luigi De Angelis, Laura Bernardini Verified, Lorenza Marconi · MDPI

    Sep. 04, 2024

  • Dabrafenib-trametinib in BRAF V600-mutated non-small-cell lung cancer: a single center real world experience

    By Andrea Sbrana, Iacopo Petrini, Laura Bernardini Verified, Sabrina Cappelli| Future Medicine Verified 1. BackgroundLung cancer represents one of the most common and malignant neoplasm worldwide. According to the last Global Cancer Statistics, lung cancer is the second cancer in terms of incidence but the first in terms of mortality worldwide [1]. Among all lung cancers, non-small-cell lung cancer (NSCLC) is the most abundant (~85%). The treatment options now available for patients with NSCLC include classical chemotherapy, targeted therapy and immunotherapy [2–5].

    By Andrea Sbrana, Iacopo Petrini, Laura Bernardini Verified, Sabrina Cappelli · Future Medicine

    May. 06, 2024

As seen in

Company Info

CNN

CNN Business is the business news division of CNN, which was founded in 1980 as the first 24-hour cable news channel. Based in Atlanta, Georgia, CNN is a subsidiary of Warner Bros. Discovery. CNN Business provides extensive coverage of global financial markets, economic trends, corporate news, technology, and personal finance. The platform offers a range of content formats, including real-time news articles, video segments, live broadcasts, market data, and financial analysis tools. It also features special reports on significant economic events and corporate developments. CNN Business serves individual investors, business professionals, and general audiences by delivering reliable and timely information to support informed financial decisions and understanding of market dynamics.

New York, New York, United States

'+1 404-827-3326

Founded: 2001